Association of Soluble Suppression of Tumorigenicity 2 Protein with New-onset Atrial Fibrillation in Patients with Acute ST-segment Elevation Myocardial Infarction Undergoing Primary PCI

Overview

Journal Front Cardiovasc Med

Specialty Cardiology & Vascular Diseases

Date 2023 Oct 9

PMID 37808879

Authors

Ting-Ting Zhao

Tian-Jiao Pan

Yi-Bo Yang

Xiao-Yang Pei

Yong Wang

Affiliations

Soon will be listed here.

Abstract

Background: Previous studies have indicated that the soluble suppression of tumorigenicity 2 protein (sST2) is associated with new-onset atrial fibrillation (NOAF) in patients diagnosed with coronary artery disease (CAD). However, the predictive value of sST2 in patients with acute ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PCI) has not been well studied.

Methods: A total of 580 patients with STEMI undergoing primary PCI were consecutively recruited between January 2021 and January 2023. These patients were then categorized into two groups: the NOAF group and the no NOAF groups based on the presence of NOAF during admission. The concentration of sST2 in blood samples was measured in all patients. The clinical data from the two groups were prospectively analyzed to investigate the predictive factors of NOAF in patients with STEMI undergoing primary PCI.

Results: A total of 41 (7.1%) patients developed NOAF. The presence of NOAF has been found to be associated with various factors, including age, diabetes mellitus, hypertension, the left atrial (LA) diameter, N-terminal pro-brain natriuretic peptide, C-reactive protein (CRP), sST2, a Killip class of ≥2, and a final TIMI flow grade of <3. After including multiple factors, it was observed that LA diameter, CRP, sST2, a Killip class of ≥2, and a final TIMI flow grade of <3 remained significant risk factors for developing NOAF. The receiver operating characteristic (ROC) curve showed the following findings: (1) when the LA diameter exceeded 38.5 mm, the sensitivity and specificity values were observed to be 67.2% and 68.2%, respectively, and the area under the ROC curve (AUC) was 0.683 [95% confidence interval (CI): 0.545-0.732; = 0.003]; (2) when the CRP level exceeded 8.59, the sensitivity and specificity values were observed to be 68.6% and 69.2%, respectively, and the AUC was 0.713 (95% CI: 0.621-0.778; < 0.001); and (3) when the sST2 value exceeded 53.3, the sensitivity and specificity values were 79.2% and 68.7%, respectively, and the AUC was 0.799 (95% CI: 0.675-0.865; < 0.001).

Conclusion: sST2 has been identified as an independent predictor of NOAF in patients with STEMI undergoing PCI.

Citing Articles

Associations Between Albumin/Neutrophil-to-Lymphocyte Ratio Score and New-Onset Atrial Fibrillation in Patients with Acute Myocardial Infarction Undergoing PCI.

Yang S, Zhao H J Inflamm Res. 2025; 18():61-71.

PMID: 39780988 PMC: 11705989. DOI: 10.2147/JIR.S500743.

Soluble suppression of tumorigenicity 2 associated with microvascular obstruction in patients with ST-segment elevation myocardial infarction.

Du X, Liu J, Zhou J, Ren Y, Gul N, Chen L BMC Cardiovasc Disord. 2024; 24(1):691.

PMID: 39614185 PMC: 11607795. DOI: 10.1186/s12872-024-04364-2.

References

Lopes R, Elliott L, White H, Hochman J, Van de Werf F, Ardissino D . Antithrombotic therapy and outcomes of patients with atrial fibrillation following primary percutaneous coronary intervention: results from the APEX-AMI trial. Eur Heart J. 2009; 30(16):2019-28. PMC: 2764954. DOI: 10.1093/eurheartj/ehp213. View

Ibanez B, James S, Agewall S, Antunes M, Bucciarelli-Ducci C, Bueno H . 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European.... Eur Heart J. 2017; 39(2):119-177. DOI: 10.1093/eurheartj/ehx393. View

Konstam M, Kramer D, Patel A, Maron M, Udelson J . Left ventricular remodeling in heart failure: current concepts in clinical significance and assessment. JACC Cardiovasc Imaging. 2011; 4(1):98-108. DOI: 10.1016/j.jcmg.2010.10.008. View

Wi J, Shin D, Kim J, Kim B, Ko Y, Choi D . Transient New-Onset Atrial Fibrillation Is Associated With Poor Clinical Outcomes in Patients With Acute Myocardial Infarction. Circ J. 2016; 80(7):1615-23. DOI: 10.1253/circj.CJ-15-1250. View

. Independent predictors of stroke in patients with atrial fibrillation: a systematic review. Neurology. 2007; 69(6):546-54. DOI: 10.1212/01.wnl.0000267275.68538.8d. View

Svartstein A, Lassen M, Skaarup K, Grove G, Vyff F, Ravnkilde K . Predictive value of left atrial strain in relation to atrial fibrillation following acute myocardial infarction. Int J Cardiol. 2022; 364:52-59. DOI: 10.1016/j.ijcard.2022.05.026. View

Biccire F, Pastori D, Torromeo C, Acconcia M, Capone S, Ferrari I . Acute atrial ischemia associates with early but not late new-onset atrial fibrillation in STEMI patients treated with primary PCI: relationship with in-hospital outcomes. J Cardiol. 2021; 78(5):368-374. DOI: 10.1016/j.jjcc.2021.05.013. View

Tyminska A, Kaplon-Cieslicka A, Ozieranski K, Budnik M, Wancerz A, Sypien P . Association of Galectin-3 and Soluble ST2, and Their Changes, with Echocardiographic Parameters and Development of Heart Failure after ST-Segment Elevation Myocardial Infarction. Dis Markers. 2019; 2019:9529053. PMC: 6811795. DOI: 10.1155/2019/9529053. View

Engelmann M, Svendsen J . Inflammation in the genesis and perpetuation of atrial fibrillation. Eur Heart J. 2005; 26(20):2083-92. DOI: 10.1093/eurheartj/ehi350. View

10.

Del Turco S, Basta G, De Caterina A, Sbrana S, Paradossi U, Taddei A . Different inflammatory profile in young and elderly STEMI patients undergoing primary percutaneous coronary intervention (PPCI): Its influence on no-reflow and mortality. Int J Cardiol. 2019; 290:34-39. DOI: 10.1016/j.ijcard.2019.05.002. View

11.

Wang T, Larson M, Levy D, Benjamin E, Leip E, Omland T . Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med. 2004; 350(7):655-63. DOI: 10.1056/NEJMoa031994. View

12.

Rene A, Genereux P, Ezekowitz M, Kirtane A, Xu K, Mehran R . Impact of atrial fibrillation in patients with ST-elevation myocardial infarction treated with percutaneous coronary intervention (from the HORIZONS-AMI [Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction] trial). Am J Cardiol. 2013; 113(2):236-42. DOI: 10.1016/j.amjcard.2013.09.016. View

13.

Kornej J, Apostolakis S, Bollmann A, Lip G . The emerging role of biomarkers in atrial fibrillation. Can J Cardiol. 2013; 29(10):1181-93. DOI: 10.1016/j.cjca.2013.04.016. View

14.

Selcuk M, Cinar T, Saylik F, Akbulut T, Asal S, Cicek V . Predictive value of uric acid/albumin ratio for the prediction of new-onset atrial fibrillation in patients with ST-Elevation myocardial infarction. Rev Invest Clin. 2022; 74(3):156-164. DOI: 10.24875/RIC.22000072. View

15.

Chirinos J, Orlenko A, Zhao L, Basso M, Cvijic M, Li Z . Multiple Plasma Biomarkers for Risk Stratification in Patients With Heart Failure and Preserved Ejection Fraction. J Am Coll Cardiol. 2020; 75(11):1281-1295. PMC: 7147356. DOI: 10.1016/j.jacc.2019.12.069. View

16.

Burstein B, Nattel S . Atrial fibrosis: mechanisms and clinical relevance in atrial fibrillation. J Am Coll Cardiol. 2008; 51(8):802-9. DOI: 10.1016/j.jacc.2007.09.064. View

17.

Chen L, Chen W, Shao Y, Zhang M, Li Z, Wang Z . Association of Soluble Suppression of Tumorigenicity 2 with New-Onset Atrial Fibrillation in Acute Myocardial Infarction. Cardiology. 2022; 147(4):381-388. DOI: 10.1159/000524765. View

18.

Kara K, Geisel M, Mohlenkamp S, Lehmann N, Kalsch H, Bauer M . B-type natriuretic peptide for incident atrial fibrillation-The Heinz Nixdorf Recall Study. J Cardiol. 2014; 65(6):453-8. DOI: 10.1016/j.jjcc.2014.08.003. View

19.

Chung M, Martin D, Sprecher D, Wazni O, Kanderian A, Carnes C . C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation. Circulation. 2001; 104(24):2886-91. DOI: 10.1161/hc4901.101760. View

20.

Ruwald A, Thomsen P, Gang U, Jorgensen R, Huikuri H, Jons C . New-onset atrial fibrillation predicts malignant arrhythmias in post-myocardial infarction patients--a Cardiac Arrhythmias and RIsk Stratification after acute Myocardial infarction (CARISMA) substudy. Am Heart J. 2013; 166(5):855-63.e3. DOI: 10.1016/j.ahj.2013.08.017. View